Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor for Cystic Fibrosis-related Constipation
NCT06810167Phase 3Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in constipation, sponsored by Massachusetts General Hospital. Started Jun 2025; status: active, not recruiting.
02
Drugs
tenapanor
03
Conditions
constipation
Beyond the preview
Go deeper on NCT06810167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06810167.